(Q46982494)

27 December 2017

title

Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans (English)

1 reference

27 December 2017

author

Hiroshi Yamazaki

10

1 reference

27 December 2017

author name string

Yoshinobu Nakamaru

1

1 reference

27 December 2017

Yoshiharu Hayashi

2

1 reference

27 December 2017

Ruriko Ikegawa

3

1 reference

27 December 2017

Shuji Kinoshita

4

1 reference

27 December 2017

Begonya Perez Madera

5

1 reference

27 December 2017

Dave Gunput

6

1 reference

27 December 2017

Atsuhiro Kawaguchi

7

1 reference

27 December 2017

Martin Davies

8

1 reference

27 December 2017

Stuart Mair

9

1 reference

27 December 2017

Toshiyuki Kume

11

1 reference

27 December 2017

Masayuki Suzuki

12

1 reference

27 December 2017

language of work or name

English

0 references

publication date

15 July 2013

1 reference

27 December 2017

published in

Xenobiotica

1 reference

27 December 2017

volume

44

1 reference

27 December 2017

issue

3

1 reference

27 December 2017

page(s)

242-253

1 reference

27 December 2017

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

In vitro metabolism of α7 neuronal nicotinic receptor agonist AZD0328 and enzyme identification for its N-oxide metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00498254.2013.816891

10.3109/00498254.2013.816891

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

PubMed ID

23855261

1 reference

27 December 2017